136 related articles for article (PubMed ID: 36943799)
1. MATE1 expression in the cochlea and its potential involvement in cisplatin cellular uptake and ototoxicity.
Waissbluth S; Martínez AD; Figueroa-Cares C; Sánchez HA; Maass JC
Acta Otolaryngol; 2023 Mar; 143(3):242-249. PubMed ID: 36943799
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of OCT2 in the cochlea of various species.
Hellberg V; Gahm C; Liu W; Ehrsson H; Rask-Andersen H; Laurell G
Laryngoscope; 2015 Sep; 125(9):E320-5. PubMed ID: 25892279
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
4. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
Ciarimboli G; Deuster D; Knief A; Sperling M; Holtkamp M; Edemir B; Pavenstädt H; Lanvers-Kaminsky C; am Zehnhoff-Dinnesen A; Schinkel AH; Koepsell H; Jürgens H; Schlatter E
Am J Pathol; 2010 Mar; 176(3):1169-80. PubMed ID: 20110413
[TBL] [Abstract][Full Text] [Related]
5. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
6. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
Saad AAA; Zhang F; Mohammed EAH; Wu X
Biol Pharm Bull; 2022; 45(4):382-393. PubMed ID: 35370262
[TBL] [Abstract][Full Text] [Related]
7. Membrane transporters as mediators of cisplatin side-effects.
Ciarimboli G
Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin.
Sauzay C; White-Koning M; Hennebelle I; Deluche T; Delmas C; Imbs DC; Chatelut E; Thomas F
Pharmacol Res; 2016 Aug; 110():89-95. PubMed ID: 27178732
[TBL] [Abstract][Full Text] [Related]
9. Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2.
Wang G; Bi Y; Xiong H; Bo T; Han L; Zhou L; Zhang C; Zhang Y
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S447-S459. PubMed ID: 34592875
[TBL] [Abstract][Full Text] [Related]
10. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
Nakamura T; Yonezawa A; Hashimoto S; Katsura T; Inui K
Biochem Pharmacol; 2010 Dec; 80(11):1762-7. PubMed ID: 20813096
[TBL] [Abstract][Full Text] [Related]
11. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
[TBL] [Abstract][Full Text] [Related]
12. Saving ears and kidneys from cisplatin.
Wensing KU; Ciarimboli G
Anticancer Res; 2013 Oct; 33(10):4183-8. PubMed ID: 24122981
[TBL] [Abstract][Full Text] [Related]
13. Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO).
Gessner A; König J; Fromm MF
Sci Rep; 2018 Apr; 8(1):6659. PubMed ID: 29704007
[TBL] [Abstract][Full Text] [Related]
14. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
Xiao G; Rowbottom C; Boiselle C; Gan LS
Pharm Res; 2018 Jun; 35(8):159. PubMed ID: 29915999
[TBL] [Abstract][Full Text] [Related]
15. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
[TBL] [Abstract][Full Text] [Related]
16. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
17. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
[TBL] [Abstract][Full Text] [Related]
18. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
[TBL] [Abstract][Full Text] [Related]
19. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
König J; Zolk O; Singer K; Hoffmann C; Fromm MF
Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
[TBL] [Abstract][Full Text] [Related]
20. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
